Japan colorectal tumor prevention study: randomized controlled trial by low-dose aspirin

ABSTRACT: Interventions: Aspirin (100 mg/day) enteric-coated tablet Placebo tablet / day Primary outcome(s): Only the occurrence of a colorectal tumor (adenoma or cancer) is selected as the primary endpoint. Study Design: Parallel Randomized

DISEASE(S): Colorectal Tumor

PROVIDER: 2616201 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR